Fewer shots for HPV protection? study tests 2-Dose vaccine schedule
NCT ID NCT04206813
Summary
This study is testing whether two doses of the Gardasil 9 HPV vaccine work as well as three doses in women aged 16-45. Researchers want to see if the immune response from two shots is strong enough to protect against HPV infection. The study involves 352 women and compares antibody levels between different age groups and dosing schedules.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
Conditions
Explore the condition pages connected to this study.